These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38738925)

  • 1. Rapid biotransformation of STW 5 constituents by human gut microbiome from IBS- and non-IBS donors.
    Thumann TA; Pferschy-Wenzig E-M; Kumpitsch C; Duller S; Högenauer C; Kump P; Aziz-Kalbhenn H; Ammar RM; Rabini S; Moissl-Eichinger C; Bauer R
    Microbiol Spectr; 2024 Jun; 12(6):e0403123. PubMed ID: 38738925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of the gut microbiome in mediating the beneficial effects of the six-herbal formulation STW 5-II on digestive health.
    Ammar RM; Pferschy-Wenzig EM; Van den Abbeele P; Verstrepen L; Ghyselinck J; Thumann T; Bauer R
    Phytomedicine; 2023 Oct; 119():154996. PubMed ID: 37595389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome.
    Zeber-Lubecka N; Kulecka M; Ambrozkiewicz F; Paziewska A; Goryca K; Karczmarski J; Rubel T; Wojtowicz W; Mlynarz P; Marczak L; Tomecki R; Mikula M; Ostrowski J
    Gut Microbes; 2016 Sep; 7(5):397-413. PubMed ID: 27662586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized clinical trial: Effects of Aloe barbadensis Mill. extract on symptoms, fecal microbiota and fecal metabolite profiles in patients with irritable bowel syndrome.
    Ahluwalia B; Magnusson MK; Böhn L; Störsrud S; Larsson F; Savolainen O; Ross A; Simrén M; Öhman L
    Neurogastroenterol Motil; 2020 Aug; 32(8):e13860. PubMed ID: 32314514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbial signatures of patients with diarrhea-predominant irritable bowel syndrome and their healthy relatives.
    Chen J; Lan H; Li C; Xie Y; Cheng X; Xia R; Ke C; Liang X
    J Appl Microbiol; 2024 Jun; 135(6):. PubMed ID: 38849305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tong-Xie-Yao-Fang strengthens intestinal feedback control of bile acid synthesis to ameliorate irritable bowel syndrome by enhancing bile salt hydrolase-expressing microbiota.
    Jia F; Du L; He J; Zhang Z; Hou X; Dong Q; Bian Z; Zhao L
    J Ethnopharmacol; 2024 Sep; 331():118256. PubMed ID: 38677571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-target Treatment for Irritable Bowel Syndrome with STW 5: Pharmacological Modes of Action.
    Allescher HD; Burgell R; Malfertheiner P; Mearin F
    J Gastrointestin Liver Dis; 2020 Jun; 29(2):227-233. PubMed ID: 32530990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome.
    Li Y; Hong G; Yang M; Li G; Jin Y; Xiong H; Qian W; Hou X
    Pharmacol Res; 2020 Sep; 159():104936. PubMed ID: 32470562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiomics Analysis Reveals Gut Virome-Bacteria-Metabolite Interactions and Their Associations with Symptoms in Patients with IBS-D.
    Xie P; Luo M; Fan J; Xiong L
    Viruses; 2024 Jun; 16(7):. PubMed ID: 39066219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Maharshak N; Ringel Y; Katibian D; Lundqvist A; Sartor RB; Carroll IM; Ringel-Kulka T
    Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel Syndrome.
    Iribarren C; Magnusson MK; Vigsnæs LK; Aziz I; Amundsen ID; Šuligoj T; Juge N; Patel P; Sapnara M; Johnsen L; Sørensen N; Sundin J; Törnblom H; Simrén M; Öhman L
    Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome.
    Zhu S; Liu S; Li H; Zhang Z; Zhang Q; Chen L; Zhao Y; Chen Y; Gu J; Min L; Zhang S
    Front Cell Infect Microbiol; 2019; 9():346. PubMed ID: 31681624
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in gut microbial metagenomic pathways associated with clinical outcomes after the elimination of malabsorbed sugars in an IBS cohort.
    Mack A; Bobardt JS; Haß A; Nichols KB; Schmid RM; Stein-Thoeringer CK
    Gut Microbes; 2020 May; 11(3):620-631. PubMed ID: 31809634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice.
    De Palma G; Lynch MD; Lu J; Dang VT; Deng Y; Jury J; Umeh G; Miranda PM; Pigrau Pastor M; Sidani S; Pinto-Sanchez MI; Philip V; McLean PG; Hagelsieb MG; Surette MG; Bergonzelli GE; Verdu EF; Britz-McKibbin P; Neufeld JD; Collins SM; Bercik P
    Sci Transl Med; 2017 Mar; 9(379):. PubMed ID: 28251905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of Action of STW 5 in Functional Dyspepsia and IBS: The Origin of Multi-Target.
    Allescher HD; Abdel-Aziz H
    Dig Dis; 2017; 35 Suppl 1():18-24. PubMed ID: 29421789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metagenomic analysis of the gut virome in patients with irritable bowel syndrome.
    Zhang P; Ma S; Guo R; Li L; Guo X; Chang D; Li S; Zhang H; Fu C; Yang L; Zhang Y; Jiang J; Wang T; Wang J; Shi H
    J Med Virol; 2024 Jul; 96(7):e29802. PubMed ID: 39023095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The microbiome of the oral mucosa in irritable bowel syndrome.
    Fourie NH; Wang D; Abey SK; Sherwin LB; Joseph PV; Rahim-Williams B; Ferguson EG; Henderson WA
    Gut Microbes; 2016 Jul; 7(4):286-301. PubMed ID: 26963804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome.
    Labus JS; Hollister EB; Jacobs J; Kirbach K; Oezguen N; Gupta A; Acosta J; Luna RA; Aagaard K; Versalovic J; Savidge T; Hsiao E; Tillisch K; Mayer EA
    Microbiome; 2017 May; 5(1):49. PubMed ID: 28457228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of gut microbiota for the activity of medicinal plants traditionally used in the European Union for gastrointestinal disorders.
    Thumann TA; Pferschy-Wenzig EM; Moissl-Eichinger C; Bauer R
    J Ethnopharmacol; 2019 Dec; 245():112153. PubMed ID: 31408679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory and tight junction protective activity of the herbal preparation STW 5-II on mouse intestinal organoids.
    Elbadawi M; Ammar RM; Aziz-Kalbhenn H; Rabini S; Klauck SM; Dawood M; Saeed MEM; Kampf CJ; Efferth T
    Phytomedicine; 2021 Jul; 88():153589. PubMed ID: 34111617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.